Immunology of Infectious Disease News 4.46 November 23, 2016 | |
| |
TOP STORYIFN-α/IFN-λ Responses to Respiratory Viruses in Pediatric Asthma The authors analyzed the influence of rhinovirus in nasopharyngeal fluid on type I and III interferon (IFN) responses and their signal transduction, at baseline and during disease exacerbation, in cohorts of pre-school children with and without asthma. [Eur Respir J] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists compared the effect of antibodies neutralizing IL-17A, IL-17F or TNFα on murine host responses to M. tuberculosis infection by evaluating lung transcriptomic, microbiological and histological analyses. [Sci Rep] Full Article Researchers utilized an infant/toddler murine model infected with influenza virus with an adult comparator. In the model, young mice exhibited lower interleukin (IL)-10+IFNγ+ co-producing CD4 T cells infiltrating the lungs that paralleled with a failed switch from an innate to adaptive immune response at the mid infection stage. [Immunol Cell Biol] Abstract Skin and skin structure infection was induced in wild-type and rag1-/- mice in BALB/c and C57BL/6 backgrounds. Compared to naïve controls, prior infection in wild-type and rag1-/- mice of either background afforded protection against repeat infection, as evidenced by reduced abscess severity and lower CFU density. [Infect Immun] Abstract Myo-pcD+recombinant heavy chain myosin of B. malayi triggered higher production of specific IgG and its isotypes which induced marked cellular adhesion and cytotoxicity to microfilariae and L3 in vitro. [PLoS One] Full Article HIVHIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C*12:02/C*14:03 Researchers investigated 504 anti-retroviral-free Japanese patients chronically infected with HIV-1 and identified two KIR/HLA combinations, KIR2DL2/HLA-C*12:02 and KIR2DL2/HLA-C*14:03, that impact suppression of HIV-1 replication. [Cell Rep] Full Article | Graphical Abstract Scientists investigated whether the autophagy pathway and/or ATG proteins are hijacked by HIV-1 Vpu to circumvent bone marrow stromal antigen 2 (BST2) restriction of viral release. [Cell Rep] Full Article | Graphical Abstract The authors report the efficacy of a mucosal HIV vaccine strategy comprising intranasal vaccination with a cocktail of live recombinant human rhinoviruses encoding overlapping fragments of HIV Gag and full length Tat followed by intradermal vaccination with DNA vaccines encoding HIV Gag and Tat. [Sci Rep] Full Article | Press Release Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease Researchers measured markers of immune activation both in pleural fluid and plasma, and in T cells in pleural fluid mononuclear cell and peripheral blood mononuclear cell in HIV/TB co-infected subjects. The relationship between soluble and T cell activation markers with viral load in pleural fluid and blood CD4 T cell count were assessed. [PLoS One] Full Article Subscribe to our sister publications: Human Immunology News & Immune Regulation News. | |
| |
REVIEWSRole of Pathogen-Associated Molecular Patterns (PAMPS) in Immune Responses to Fungal Infections The authors highlight the role of Toll-like receptor participants in fungal recognition as well as their mechanisms. [Eur J Pharmacol] Abstract Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field. | |
| |
SCIENCE NEWSABIVAX to Present Phase IIa Clinical Data on ABX464 ABIVAX announced today that the Company is presenting clinical data on ABX464, ABIVAX’s first-in-class drug candidate for the treatment of patients with HIV/AIDS. [Press release from ABIVAX discussing research presented at the NIH/NIAID-Sponsored Strategies for an HIV Cure Meeting 2016, Bethesda] Press Release | |
| |
INDUSTRY NEWSTheratechnologies Inc. announced that it has been notified by its partner, TaiMed Biologics, Inc., of the preliminary results for the safety and efficacy secondary endpoints of the 24-week Phase III trial with ibalizumab in patients with multi-drug resistant HIV-1. [Theratechnologies Inc.] Press Release Integral Molecular Isolates Zika-Specific Monoclonal Antibodies for Vaccine Research and Diagnostics Integral Molecular announced the isolation of neutralizing monoclonal antibodies specific for the Zika virus envelope, thereby enabling vital vaccine research and the development of improved diagnostics to combat the ongoing Zika epidemic. [Integral Molecular] Press Release Yisheng Biopharma Co., Ltd. announced the completion of Phase I clinical trial of PIKA Hepatitis B vaccine, an investigational vaccine designed to provide both prophylactic and therapeutic benefits against hepatitis B virus infection. [Yisheng Biopharma Co., Ltd. (PR Newswire Association LLC.)] Press Release | |
| |
POLICY NEWSNgAgo Gene-Editing Controversy Escalates in Peer-Reviewed Papers A heated dispute over gene-editing that began online is now playing out in the scientific literature. Six months ago, Chinese researchers reported that an enzyme called NgAgo could be used to edit mammalian genes – and that it might be more accurate and more versatile than the popular CRISPR-Cas9 gene-editing technique. [Nature News] Editorial Immigrant and Minority Scientists Shaken by Trump Win Scientists are reconsidering whether to work or study in the United States. Worries include job prospects, discrimination—and safety. [Nature News] Editorial Peer-Review ‘Heroes’ Do Lion’s Share of the Work In 2015, the number of scientists in the life sciences far exceeded the demand on them for peer review, according to Michail Kovanis, a computational physicist at the French National Institute of Health and Medical Research in Paris, and his colleagues. Yet their study also suggests – based on data obtained from a rapidly-growing website of peer-review activity – that 20% of the scientists undertook between 69% and 94% of reviews last year, lending credence to some researchers’ complaints that they are overburdened. [Nature News] Editorial Cautious Welcome for UK’s Vague £2 Billion Research Pledge UK scientists have welcomed a surprise government promise to invest an extra £2 billion (US$2.5 billion) per year into research and development by 2020 – although details of the pledge will not be made clear for at least another two days. [Nature News] Editorial Conservatives, Liberals Team Up against Animal Research “Painful, bizarre, and wasteful experiments.” Buying dogs “just to cut them apart … and kill them.” These statements might sound like the rhetoric used by extreme animal rights groups, but they come from White Coat Waste—a new, unlikely coalition of fiscal conservatives and liberal activists that aims to end federal funding for research involving dogs and other animals by targeting people’s pocketbooks in addition to their heartstrings. [ScienceInsider] Editorial
| |
EVENTSNEW Translational Opportunities in Stem Cell Research Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Immunology of HIV-1 and Cancer (University of Alabama at Birmingham) NEW Postdoctoral Research Scientist – Infection (Rush University Medical Center) Research Technologist – Cell Separation (STEMCELL Technologies Inc.) Research Fellow – HIV Research (Dana-Farber Cancer Institute) Postdoctoral Fellow – Immunology of Chronic HBV Infection (F. Hoffmann-La Roche) Project Research Scientist – Malaria Research (The Francis Crick Institute) PhD Prize Studentships (University of Oxford) Postdoctoral Position – Immunology (Klinikum der Universität München) Faculty Positions – Immunology (Ohio State University) Faculty Position – Senior Immunologist (Fred Hutchinson Cancer Research Center) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|